HYRO

Strategic growth round 2026

Australia's premium hydration brand.

Built for the next billion-dollar exit window. A$3M to A$5M strategic growth round at approximately A$30M post-money.

A$3M to A$5M round~A$30M post-moneyFounder-led process

ConfidentialWorking draft v0.3
May 2026

FAST

Investment snapshot

Real recurring revenue, real unit economics, real category timing.

A$7.14M

AU subscription ARR, ex GST

9,111

Active subscribers

+1,421

Trailing 30-day net subscriber adds

78%

April 2026 cohort sub attach rate

3.55x

M16 GP LTV:CAC, actual

Capital funds the United States launch, retention engineering, retail acceleration and the next hero SKU.

NOW

Why now

The category just paid out twice.

Strategic appetite is here

Unilever acquired Grüns for approximately US$1.2B in April 2026 after roughly 24 months.
Liquid I.V. proved the strategic exit path before it.
IM8 reportedly reached approximately US$120M ARR in twelve months.

Hyro fits the pattern

Premium daily wellness format with repeat-use behaviour.
Subscription-native revenue from day one.
Creator-investor distribution instead of paid-post dependency.
AI operating leverage that compresses team cost and execution time.

Comparable-company references are category timing context, not direct valuation comparables.

Subscription wins the wellness shelf

Hyro is built around recurring revenue from day one.

The strongest hydration brands are habit brands. Hyro has already turned flavour-led hydration into a subscription engine with lifetime gross-profit economics, not just transactional gross profit.

What has been proven

A$595K active product MRR ex GST.
A$65.31 ARPU per subscriber.
Three-month gross-profit payback.

Why it matters

More valuable revenue mix.
Cleaner cohort visibility.
Retention engine improving with scale.

PROOF

The proof stack

Investor-grade metrics across revenue, margin, acquisition and retention.

A$4.13M

FY25-26 revenue ex GST

A$9-10M

Forward run rate, combined

57%

Gross margin, FY25-26

A$68

Weighted-average subscriber CAC

A$880

Mar-Apr 2026 cohort M36 LTV forecast

6.11x

GP LTV:CAC, month 36 forecast

150+

Wholesale accounts onboarded

17,894

Subscribers in reconciled cohort dataset

Reconciled cohort dataset across 19 cohorts, Skio, 2026-05-05. Most recent cohorts, Mar-Apr 2026, n=5,630, project the strongest M36 LTV in the dataset.

Creator-investor distribution

Equity ambassadors, not paid posters.

Sarah's Day

1.3M+ audience. Co-creator of the hero flavour and a structural distribution partner.

Elite sport

Quade Cooper, Daly Cherry-Evans, Kendrick Louis and athlete network credibility.

Creator leverage

Dan Churchill plus a broader founder-led creator-investor network that compounds trust.

Distribution is structuralCommunity first
media second

2026

2026 revenue scenarios

Multiple ways to win in the next twelve months.

Base

A$12M

Target

A$15M

Upside

A$18M

Target bridge to A$15M

AU subscription: A$7.1M
One-time DTC: A$1.9M
Wholesale and retail: A$1.6M
US launch: A$2.0M
Creatine and new SKUs: A$2.4M

What the scenarios imply

The base case can be underwritten from an already scaled recurring engine.
The target case is mostly execution, not invention.
The upside case requires the US and new SKU engine to hit early.

US

United States launch

Australia proved the model. The US is the scale unlock.

The US Shopify Plus store is live. The brand already has proof in Australia. The round gives Hyro the inventory, creator activation and paid media fuel to move properly.

Launch infrastructure

US store live on drinkhyro.co.
US operating setup underway.
3PL readiness being built.

Demand engine

Creator seeding and paid media.
Stage-gated to CAC and cohort proof.
AU learnings exported to a larger market.

Next hero SKU

Creatine and new SKUs expand the routine.
More reasons to subscribe.
More shelf and social relevance.

Internal AI operating system

Six-person team, fifteen-person throughput.

Hyro has an AI operating layer across growth, finance, supply chain, customer experience and founder leverage. This is a margin and speed lever in every function, not a tech bet.

Hermes

Chief-of-staff layer, execution orchestration and founder leverage.

Apollo

Paid media, creative intelligence and growth operating rhythm.

Atlas

Inventory, supply chain, purchasing and operational visibility.

Plutus + Lisa

Finance cockpit, customer inbox execution and escalation discipline.

Use of funds

Capital goes directly into the next growth step.

US paid media and creator activation

58%

Inventory depth and 3PL readiness

14%

Creator operations and creative production

10%

US growth lead

10%

R&D, Creatine launch and working capital

8%

ROUND

Round structure

A curated round for strategic capital.

A$3M-A$5M

Round size

~A$30M

Post-money valuation anchor

10.0%-16.7%

Dilution range

A$2.2M

Capital raised to date

~4.2x

Multiple on AU subscription ARR

Implied multiples

~3.0x to 3.3x on forward run rate.
~2.0x on 2026 base revenue.
~1.6x on 2026 target revenue.

What we are looking for

Category operating experience in functional wellness, beverage or recurring-revenue consumer.
US distribution or retail relationships.
Creator-led acquisition or athlete equity partnership depth.
Strategic acquirer context in the category.

Next step

IM v0.5 plus data room under NDA.

This round is not open to passive capital. The right investor helps Hyro turn a proven Australian subscription engine into a global hydration platform.

Forward-looking statements are working scenarios, not board-approved forecasts. Final round terms subject to definitive documentation, board approval and customary diligence. Unit economics sourced from the Skio cohort LTV pack reconciled against Lifetimely blended CAC and Northbeam corrected spend. All financial figures stated ex GST.

Steve
Chapman

Founder and CEO · Hyro

steve@drinkhyro.com
+61 420 315 541
hyro-raise.pages.dev

Investor Presentation